Completion of the Icatibant Outcome Survey and What We Learned

Clinical & Experimental Allergy 2026 Open access

Read full text
Authors: Laurence Bouillet, Werner Aberer, Teresa Caballero, Anete Sevciovic Grumach, Hilary J Longhurst, Alissa R. Dangel, Natalie Khutoryansky, Irmgard Andresen, Andrea Zanichelli
DOI: 10.1111/cea.70271
Cited by: 0
References: 9

Abstract

Summary The Icatibant Outcome Survey observational registry began in 2009 to monitor the safety and effectiveness of icatibant. Fifteen years of icatibant use support effectiveness in hereditary angioedema, with no new safety signals.

Fields of Study & Subjects

Coagulation Bradykinin Polyphosphates and Angioedema Mast cells and histamine Hemophilia Treatment and Research

Publication details

Journal / source
Clinical & Experimental Allergy
Volume
56
Issue
7
Pages
784–787
Publication date
10 March 2026
Language
EN